The Association Between Time in Range With Markers of Endothelial and Cardiovascular Function
ConditionType 1 Diabetes
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-80
SponsorAttikon Hospital
About this trial
In this observaltional study, 90 patients aged \>12 years old with T1DM who are on MiniMed 780G system will be included.We aim to investigate the association between time in range (70-140mg/dl) and time in tight range (70-180mg/dl) with markers of endothelial and cardiovascular function.
Eligibility criteria
Qualifiers
Clinical diagnosis of type 1 diabetes >1 year prior to consent date. Diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not required.
HbA1c < 12.5%
Age >7years at the initiation of the system
Multiple Daily Injections (Basal Bolus therapy) with Total daily insulin use of great than 8.0 units per day over a 1-week period
Disqualifiers
None
Trial design
Treatments tested in this trial
- MiniMed 780G
Treatment groups
90 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov